BioMarin Pharmaceutical Inc. buy Oppenheimer Holdings Inc.
Start price
24.02.25
/
50%
€66.28
Target price
24.02.26
€93.59
Performance (%)
-33.06%
Price
15.12.25
€44.37
Summary
This prediction is currently active. Massive losses of -33.06% have been the result for the BUY prediction by Oppenheimer_Holdings. This prediction currently runs until 24.02.26. The prediction end date can be changed by Oppenheimer_Holdings at any time. Oppenheimer_Holdings has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| BioMarin Pharmaceutical Inc. | -3.143% | -3.143% |
| iShares Core DAX® | 0.795% | 1.458% |
| iShares Nasdaq 100 | -3.088% | -0.762% |
| iShares Nikkei 225® | -0.952% | -2.268% |
| iShares S&P 500 | -1.393% | 0.199% |
Comments by Oppenheimer_Holdings for this prediction
In the thread BioMarin Pharmaceutical Inc. diskutieren
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) was upgraded by analysts at Oppenheimer Holdings Inc. from a "market perform" rating to an "outperform" rating. They now have a $98.00 price target on the stock.
Ratings data for BMRN provided by MarketBeat